ESOC 2024: “Is Inflammation the Next Frontier in Stroke Prevention?”

#BloggingStroke contributor Bastien Rioux recaps this #ESOC2024 session co-chaired by Arthur Liesz & Ethem Murat Arsava. María A. Moro Aristeidis Katsanos

ahajournals.org/do/10.1161/blo…

Less and less enthusiasm for TXA following SAH each passing day. This paper in Neurology Journal shows no improvement in either good or poor grade patients. Nice editorial by Prajwal Ciryam & Nicholas Morris Maryland Neurology Residency European Stroke Org World Stroke Org
neurology.org/doi/10.1212/WN…

ESOC 2024 Session Report: “Thrombolysis” ahajournals.org/do/10.1161/blo…

In hospitals without access to advanced imaging, can plain CT help select pts for EVT in the late time window? Analysis in Neurology Journal by CLEAR team suggests that noncontrast CT is useful. Improved functional outcome with EVT, higher sICH Thanh Nguyen 🇺🇦
neurology.org/doi/10.1212/WN…

Check out some key sex differences in stroke Seemant Chaturvedi Cheryl Bushnell, MD, MHS, FAHA Amy Yu, MD Aleksandra Pikula MD DipABPN/ABLM 🧠 Cheryl Carcel Brown EM Residency Brown Emergency Medicine #StrokeMonth

Article Commentary: “Apixaban to Prevent Recurrence After Cryptogenic Stroke in Patients With Atrial Cardiopathy”

In this #BloggingStroke post, Sucharita Ray discusses JAMA article by Hooman Kamel et al. Seemant Chaturvedi Dawn Kleindorfer, MD Mitchell Elkind

ahajournals.org/do/10.1161/blo…

'There was no benefit and possibly harm in nondisabling minor stroke patients with intracranial occlusion treated with intravenous tenecteplase,' ShelaghCouttsMD says European Stroke Org #ESOC2024 tctmd.com/news/tempo-2-t…

Pleased to provide commentary on some of the tenecteplase data that emerged from ESOC. This seems like icing on the cake to me and switching to TNK is a sensible strategy Eva A. Mistry, MBBS, MSCI, FAHA Todd Neale European Stroke Org World Stroke Org American Academy of Neurology
tctmd.com/news/more-tria…

Delighted to welcome Malik Ghannam and the great stroke team from Univ of Iowa to the SCORE Registry. We look forward to their contributions in trying to identify the best treatments for symptomatic carotid stenosis Luciano Sposato 🇦🇷🇨🇦 Thanh Nguyen 🇺🇦 Bijoy K Menon Shadi Yaghi

Congrats to Simona Sacco for becoming ESO President! Look forward to her term, and taking a great organization higher European Stroke Org World Stroke Org Carlos Molina Urs Martin Fischer valeria caso Gian Marco De Marchis, MD MSc Stroke AHA/ASA

An added bonus of visiting Basel is getting to see the Old Boys tennis club, where Roger polished his game, on the way to becoming the all time Wimbledon champ and ultimate sportsman. Great Federer Super-fan experience! ⁦European Stroke Org⁩

Fantastic job by the organizing committee of #ESOC2024 . Full of knowledge to move the field of stroke forward. Soaking in the sites of Basel post-conference ⁦European Stroke Org⁩ ⁦Urs Martin Fischer⁩ ⁦Gian Marco De Marchis, MD MSc⁩

ATTENTION IA shows no advantage in providing IA lytic therapy in patients with posterior circulation occlusions who have received EVT. May increase risk of sICH ⁦SVIN⁩ ⁦World Stroke Org⁩ #ESOC2024

#SELECT2 subanalysis: association of ischemic core hypodensity on EVT treatment effect. Volume <26 HU(ml) was associated with lower odds of mRS 0-3 at 90D (p for interaction <.001). No benefit of EVT among patients with ⬆️ volume of hypodensity.
#ESOC2024 #VoiceOfStroke

7 year results of CASSISS shows no benefit with intracranial stenting in pts with 70-99% symptomatic ICAS. Reinforces current guidelines #ESOC2024 ⁦SVIN⁩ ⁦World Stroke Org⁩

Just Published #ESOC2024 Endovascular versus medical therapy in posterior cerebral artery stroke: role of baseline NIHSS and occlusion site IL Christian H Nolte Thanh Nguyen 🇺🇦 Simon Nagel Marios Psychogios @shadiyaghi2 @ashupjadhav Hesham Masoud Vasu Saini Lorena Viana

TEMPO 2 shows no benefit with TNK in patients with minor stroke and documented vascular occlusion or perfusion deficit. Now online in tomasz baniak #ESOC2024

'This may be an instance where treatment with colchicine may be reasonable and could be considered on a case-by-case basis, depending on the patient’s risk factor profile,' Seemant Chaturvedi says #ESOC2024 European Stroke Org TCTMD tctmd.com/news/colchicin…

#ESOC2024
📢NEWS Basilar ESO guideline
👉IVT up to 24 hs
👉EVT up to 24 hs for NIHSS ≥10
👉EVT/IVT if NOT extensive y/or brainstem isquemia
👉Aspiration better than stent retriever
👉Rescue PTA/stenting if failed EVT
👉Add APT if complicated EVT an not IVT

INTERACT 4 tested ambulance based BP lowering. Improved outcomes in patients with ICH, worse outcomes with ischemic stroke. Supports the concept of Code ICH ⁦NEJM⁩ ⁦World Stroke Org⁩ #ESOC2024